Personalised risk prediction tools for cryptococcal meningitis mortality to guide treatment stratification; a pooled analysis of two randomised-controlled trials
View ORCID ProfileT.H.A. Samuels, View ORCID ProfileS.F. Molloy, View ORCID ProfileD.S. Lawrence, View ORCID ProfileA. Loyse, C. Kanyama, View ORCID ProfileR.S. Heyderman, W.S. Lai, View ORCID ProfileS. Mfinanga, S. Lesikari, View ORCID ProfileD. Chanda, View ORCID ProfileC. Kouanfack, View ORCID ProfileE. Temfack, View ORCID ProfileO. Lortholary, View ORCID ProfileM.C. Hosseinipour, View ORCID ProfileA.K. Chan, View ORCID ProfileD.B. Meya, View ORCID ProfileD.R. Boulware, View ORCID ProfileH.C. Mwandumba, View ORCID ProfileG. Meintjes, View ORCID ProfileC. Muzoora, M. Mosepele, View ORCID ProfileC.E. Ndhlovu, View ORCID ProfileN. Youssouf, View ORCID ProfileT.S. Harrison, View ORCID ProfileJ.N. Jarvis, View ORCID ProfileR.K. Gupta
doi: https://doi.org/10.1101/2024.07.10.24310212
T.H.A. Samuels
1Division of Infection and Immunity, University College London - London (United Kingdom)
S.F. Molloy
2Centre for Global Health, Institute for Infection and Immunity - St. George’s University of London - London (United Kingdom)
D.S. Lawrence
3Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine - London (United Kingdom)
4Botswana Harvard Health Partnership - Gaborone (Botswana)
5School of Pathology, Faculty of Health Sciences, University of the Witwatersrand – Johannesburg (South Africa)
A. Loyse
2Centre for Global Health, Institute for Infection and Immunity - St. George’s University of London - London (United Kingdom)
C. Kanyama
6The University of North Carolina Project – Lilongwe (Malawi)
7Kamuzu Central Hospital, Lilongwe - Lilongwe (Malawi)
R.S. Heyderman
1Division of Infection and Immunity, University College London - London (United Kingdom)
8Malawi–Liverpool–Wellcome Trust Clinical Research Programme - Blantyre (Malawi)
W.S. Lai
9NIHR Biomedical Research Centre Clinical and Research Informatics Unit, University College London Hospitals NHS Foundation Trust – London (United Kingdom)
S. Mfinanga
10The National Institute for Medical Research, Muhimbili Medical Research Centre - Dar Es Salaam (Tanzania)
S. Lesikari
10The National Institute for Medical Research, Muhimbili Medical Research Centre - Dar Es Salaam (Tanzania)
D. Chanda
11Institute for Medical Research and Training - Lusaka (Zambia)
12University Teaching Hospital - Lusaka (Zambia)
C. Kouanfack
13University of Dschang - Dschang (Cameroon)
14Hôpital Central Yaoundé/ Site Agence Nationale de Recherche sur le Sida (ANRS) Cameroun, - Yaoundé (Cameroon)
E. Temfack
15Molecular Mycology Unit, Institut Pasteur - Paris (France)
16Douala General Hospital - Douala (Cameroon)
O. Lortholary
17Paris Descartes University - Paris (France)
18Necker Pasteur Center for Infectious Diseases and Tropical Medicine - Paris (France)
19Assistance Publique–Hôpitaux de Paris - Paris (France)
M.C. Hosseinipour
6The University of North Carolina Project – Lilongwe (Malawi)
7Kamuzu Central Hospital, Lilongwe - Lilongwe (Malawi)
20University of North Carolina, Chapel Hill - North Carolina (United States)
A.K. Chan
21The Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto - Toronto (Canada)
22Dignitas International, Zomba Central Hospital - Zomba (Malawi)
D.B. Meya
23Infectious Diseases Institute, College of Health Sciences, Makerere University - Kampala (Uganda)
24University of Minnesota - Minneapolis, Minnesota (United States)
25Department of Medicine, School of Medicine, Makerere University - Kampala (Uganda)
D.R. Boulware
24University of Minnesota - Minneapolis, Minnesota (United States)
25Department of Medicine, School of Medicine, Makerere University - Kampala (Uganda)
H.C. Mwandumba
8Malawi–Liverpool–Wellcome Trust Clinical Research Programme - Blantyre (Malawi)
26Department of Medicine, Kamuzu University of Health Sciences - Blantyre (Malawi)
27Liverpool School of Tropical Medicine - Liverpool (United Kingdom)
G. Meintjes
28Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town - Cape Town (South Africa)
29Department of Medicine, University of Cape Town - Cape Town (South Africa)
30Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London - London (United Kingdom)
C. Muzoora
31Mbarara University of Science and Technology - Mbarara (Uganda)
M. Mosepele
4Botswana Harvard Health Partnership - Gaborone (Botswana)
32Department of Internal Medicine, University of Botswana - Gaborone (Botswana)
C.E. Ndhlovu
33Internal Medicine Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe - Harare (Zimbabwe)
N. Youssouf
3Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine - London (United Kingdom)
4Botswana Harvard Health Partnership - Gaborone (Botswana)
T.S. Harrison
2Centre for Global Health, Institute for Infection and Immunity - St. George’s University of London - London (United Kingdom)
J.N. Jarvis
3Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine - London (United Kingdom)
4Botswana Harvard Health Partnership - Gaborone (Botswana)
R.K. Gupta
34UCL Respiratory, Division of Medicine, University College London – London (United Kingdom)
- Supplementary Appendix[supplements/310212_file02.pdf]
Posted July 10, 2024.
Personalised risk prediction tools for cryptococcal meningitis mortality to guide treatment stratification; a pooled analysis of two randomised-controlled trials
T.H.A. Samuels, S.F. Molloy, D.S. Lawrence, A. Loyse, C. Kanyama, R.S. Heyderman, W.S. Lai, S. Mfinanga, S. Lesikari, D. Chanda, C. Kouanfack, E. Temfack, O. Lortholary, M.C. Hosseinipour, A.K. Chan, D.B. Meya, D.R. Boulware, H.C. Mwandumba, G. Meintjes, C. Muzoora, M. Mosepele, C.E. Ndhlovu, N. Youssouf, T.S. Harrison, J.N. Jarvis, R.K. Gupta
medRxiv 2024.07.10.24310212; doi: https://doi.org/10.1101/2024.07.10.24310212
Personalised risk prediction tools for cryptococcal meningitis mortality to guide treatment stratification; a pooled analysis of two randomised-controlled trials
T.H.A. Samuels, S.F. Molloy, D.S. Lawrence, A. Loyse, C. Kanyama, R.S. Heyderman, W.S. Lai, S. Mfinanga, S. Lesikari, D. Chanda, C. Kouanfack, E. Temfack, O. Lortholary, M.C. Hosseinipour, A.K. Chan, D.B. Meya, D.R. Boulware, H.C. Mwandumba, G. Meintjes, C. Muzoora, M. Mosepele, C.E. Ndhlovu, N. Youssouf, T.S. Harrison, J.N. Jarvis, R.K. Gupta
medRxiv 2024.07.10.24310212; doi: https://doi.org/10.1101/2024.07.10.24310212
Subject Area
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3112)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13049)
- Forensic Medicine (13)
- Gastroenterology (862)
- Genetic and Genomic Medicine (4871)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3072)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (963)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (502)
- Neurology (4641)
- Nursing (247)
- Nutrition (689)
- Oncology (2395)
- Ophthalmology (679)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (307)
- Palliative Medicine (88)
- Pathology (516)
- Pediatrics (1243)
- Primary Care Research (522)
- Public and Global Health (7206)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (514)
- Toxicology (65)
- Transplantation (222)
- Urology (190)